Steven Cress talks to Kim Khan on using a safety/growth strategy amid this market selloff. The stock market is beholden to Washington at present, which is prompting a rotation. (1:29) Fundamentals ultimately prevail. (2:47) Time for a barbell approach. (3:01) Dividend picks. (9:22) Growth picks. (13:58) Using Quant Ratings for early warning signs. (20:18)

Read our transcripts

Show Notes:
Brace For Turbulence

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions

Persistent volatility continues to grip the crypto market ahead of President Trump's much-anticipated summit this Friday. Given this, we thought it would be helpful for investors to hear a compilation of Bitcoin conversations we've had over the past 6 months.

Show Notes:
Kirk Spano On Bitcoin, Options Selling And A Choppy 2025
SPY, QQQ, And Bitcoin
Bitcoin Vs. Gold: What Investors Should Know
Keep Calm And Buy Bitcoin
Wall Street Breakfast

Read our episode transcripts

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions

Steven Cress on the market starting to rotate quite heavily into defensive sectors (0:40). Emma Johnston, The Country Investor, shares what's driving market uncertainty in 2025 (2:30). Staying disciplined with companies that have strong fundamentals (7:30). 3 dividend stocks, beginning with VICI Properties (10:25). 3 stocks to buy on the dip (16:00). Contextualizing recent drops in Steve's top 2025 picks (23:05). This is an excerpt from a recent webinar.

Show Notes:
Alpha Picks

Read our episode transcripts

Pursuing social anxiety disorder with MDMA. Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds (1:30). Standing on the shoulders of Johnson & Johnson's Spravato (4:00). Upcoming milestones and clinical trials (13:15). Psychedelic industry sentiment; RFK Jr influence (30:40).

Show Notes:
Psychedelic Stocks: Focus On Their Cash
Deep Dive: Atai Life Sciences
FDA's MDMA Decision A Setback, But Long-Term Outlook For Psychedelic Stocks Unchanged

Read our episode transcripts

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions

Meb Faber talks to Kirk Spano about shareholder yield, ETFs, and what tends to happen at the end of secular booms (2:50). A slightly less strong USD; foreign and emerging markets (5:25). Fixed income markets, overbuying TLT, approaching bonds with tactical yield ETF (9:30). Bitcoin cheerleading (18:00). 

Show Notes:
Meb Faber Research
Kirk Spano On Bitcoin, Options Selling And A Choppy 2025
YouTube interview

Read our episode transcripts

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions

The importance of total returns, according to Kai from Smart Money with Kai; focusing on S&P 500 + Nasdaq 100 ETFs and Bitcoin (1:30) Buying outside the US (3:30). ETFs over individual stocks (6:10). Portfolio picks: Set it and forget it? (11:45) Thematic ETFs: treat your portfolio like a pyramid (16:20). Bitcoin exposure without ETFs (19:30). Not everybody needs to own real estate (22:30).

Show Notes:
ETFs Have Come A Long Way
Smart Money Club
Smart Money with Kai

Read our episode transcripts

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions

Raul Shah from DocShah Financial explains why he focuses on value investing (0:35). Raul's process for stock-picking (6:30). Hims & Hers Health as an example of a good stock to buy (9:20). Recent and upcoming earnings: Ispire and Bank7; Talkspace and HIMS (14:40).

Show Notes:
Hims & Hers Health: A Lesson In Psychology
Talkspace: A Growth Story
Ispire: Underfollowed, Undercovered, And Undiscovered Gem
Bank7: A Growth Bank Stock

Read our episode transcripts

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions

Sara Awad from Tech Stock Pros and investing group Tech Contrarians, explains the DeepSeek story and contextualizes Nvidia concerns (1:15). Downgrading AMD (8:00). Palantir's run (10:00). Recent earnings from semi caps - 3 stocks to like (18:30). Fundamentals vs. hype, supply and demand (22:30).

Show Notes:
AMD: Don't Mistake This As A Buying Opportunity
Reddit: Buying The Underdog For Its Pace Of Growth
Palantir: A Favorable Mix Of Pro-AI And Anti-China
Meta Platforms: DeepSeek Works In Its Favor, Not Against It - A Tech Favorite

Read episode transcripts

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions

Alex King runs Growth Investor Pro and discusses hedging the QQQ, especially helpful for volatile times (0:30). Recognize patterns, find a charting method like Elliot Wave and Fibonacci (3:40). Why brokers make a huge difference (5:50). Practical example of hedging (9:00). Leveraged ETF options (13:00). This is an excerpt from Hedging Bets in Tech, published here with video and slides.

Show Notes:
Growth Investor Pro
Predictive Analytic Models by Robert P. Balan

Read episode transcripts

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions

According to Julian Lin, we're absolutely in a bubble once again. Why valuation is essential to any investment thesis (1:20). Palantir soaring this week, but valuation matters (7:15). Analyzing Palantir's stock-based compensation (16:30). Failing valuation grade and fairly valued price target (22:00).

Subscribe to Julian's Best of Breed Growth Stocks

Show Notes:
Not A Bubble! Julian Lin On Tech's Profitability And Reasonable Valuations
Julian Lin On Palantir, Google, Meta And Apple
Reddit: Julian Lin's Top Conviction Idea
Palantir Q4: Nvidia Moment Is Here, But Something's Not Right

Read our transcripts

For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions